USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
AUTOIMMUNE TECHNOLOGIES, LLC
Address:
AUTOIMMUNE TECHNOLOGIES, LLC
1010 Common Street, Suite 1705
NEW ORLEANS, LA
Phone:
N/A
URL:
N/A
EIN:
721302383
DUNS:
946839156
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,370,399.00 2
SBIR Phase II $2,633,977.00 1
STTR Phase I $1,022,739.00 2

Award List:

DIAGNOSTIC TEST FOR CHRONIC FATIGUE AND FIBROMYALGIA

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$65,690.00
Agency:
HHS
Principal Investigator:
Wilson, russell b
Abstract:
The long-term goal is to demonstrate that the Anti-Polymer Antibody Assay is diagnostic for chronic fatigue syndrome patients and fibromyalgia patients. In a pilot study 55 % (6/11) of chronic fatigue syndrome patient sera, 71 % (12/17) of fibromyalgia patient sera and 9 % (1/11) sera from healthy… More

Peptide drugs against influenza virus

Award Year / Program / Phase:
2006 / STTR / Phase I
Award Amount:
$922,901.00
Agency:
HHS
Principal Investigator:
Research Institution:
TULANE UNIVERSITY OF LOUISIANA
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Influenza virus is one of the most important human pathogens accounting for widespread morbidity and mortality. Influenza virus is currently classified as a NIAID Biodefense Category C priority pathogen, a status that may be upgraded due to the recent emergence… More

Peptide inhbitors of influenza entry-FAST TRACK

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$1,304,709.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the very young, the elderly and persons with chronic medica l conditions can develop post-flu pneumonia… More

Peptide inhbitors of influenza entry-FAST TRACK

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$2,633,977.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the very young, the elderly and persons with chronic medica l conditions can develop post-flu pneumonia… More